MedTrace Logo

The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry

NCT02346435 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-03-05

No results posted yet for this study

Summary

Retrospective studies indicate that active surveillance for clinically localized, small renal masses (cT1a, \<=4cm) is safe. It is our hypothesis that active surveillance is safe and efficacious when compared prospectively to patients undergoing immediate intervention for their small renal mass.

Conditions

  • Kidney Neoplasm

Sponsors & Collaborators

Principal Investigators

  • Mohamad E Allaf, MD, MBA · Johns Hopkins University

  • Nirmish Singla · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02346435 on ClinicalTrials.gov